| PERIOD ENDING | 27-Jun-09 | 28-Mar-09 | 27-Dec-08 | 27-Sep-08 | | Total Revenue | 8,596,000 | 8,087,000 | 9,599,000 | 9,445,000 | | Cost of Revenue | 6,998,000 | 15,182,000 |
-
|
-
| | | Gross Profit | 1,598,000 | (7,095,000) | 9,599,000 | 9,445,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative |
-
| (8,496,000) | 8,382,000 | 7,993,000 | | Non Recurring | 21,000 | 305,000 |
-
|
-
| | Others |
-
|
-
|
-
| 91,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,577,000 | 1,096,000 | 1,217,000 | 1,361,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
| 261,000 | 188,000 | | Earnings Before Interest And Taxes | 2,293,000 | 568,000 | 1,478,000 | 1,688,000 | | Interest Expense | 342,000 | (139,000) | 139,000 | 301,000 | | Income Before Tax | 1,951,000 | 707,000 | 1,339,000 | 1,387,000 | | Income Tax Expense | 626,000 | 348,000 | 488,000 | 490,000 | | Minority Interest | (77,000) | (40,000) | (6,000) | (137,000) | | | | Net Income From Continuing Ops | 954,000 | 613,000 | 845,000 | 760,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 954,000 | 613,000 | 845,000 | 760,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $954,000 | $613,000 | $845,000 | $760,000 |
|
0.29% Nasdaq 
Income Statement
